Skip to main content

Table 1 Demographics and characteristics of severe COVID-19 patients in 1-year follow-up

From: One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment

Variables

Follow-up after 1 year

Total patients (n = 25)

hUC-MSCs (n = 8)

Control (n = 17)

P value#

Age, years, median (IQR)

51.00 (45.00,67.00)

50.50 (39.00, 72.75)

52.00 (45.00,63.00)

0.521

Male

11 (44.00%)

4 (50.0%)

7 (41.18%)

1.000

Smokers

7 (28.00%)

3 (37.5%)

4 (23.53%)

0.640

Body mass index (BMI)

26.08 (22.16,27.99)

22.91 (20.40, 24.43)

26.08 (21.51,27.99)

0.181

Diabetes/hypertension

10 (40.00%)

4 (50.0%)

6 (35.29%)

0.667

Blood routine examination

WBC, median (IQR), 109 /L

5.60 (4.79,6.07)

5.62 (4.98,6.27)

5.60 (4.73,6.07)

0.813

NEU, 109 /L

3.24 (2.65,3.84)

3.05 (2.24,4.15)

3.27 (2.65,3.76)

0.979

LYM, 109 /L

1.76 (1.42,2.02)

1.77 (1.26,2.02)

1.76 (1.49,2.02)

0.543

MON, 109 /L

0.31 (0.22,0.45)

0.26 (0.20,0.47)

0.31 (0.26,0.45)

0.776

HB, g/L

143.00 (130.00,156.00)

152.50 (128.75,162.50)

141.00 (130.00,152.50)

0.233

PLT, 109 /L

227.00 (200.50,259.50)

243.00 (194.75,261.75)

226.00 (200.50,264.50)

0.745

Blood biochemistry

AST, U/L

21.00 (16.50,25.00)

22.50 (15.00,32.00)

21.00 (18.00,23.50)

0.400

ALT, U/L

21.00 (14.00,30.00)

27.50 (19.25,36.25)

20.00 (13.50,24.00)

0.286

K, mmol/L

4.23 (3.98,4.47)

4.40 (4.27,4.77)

4.08 (3.92,4.37)

0.143

Na, mmol/L

142.10 (140.45,142.70)

141.05 (139.63,142.10)

142.30 (141.30,142.95)

0.141

Cl, mmol/L

107.30 (105.55,108.80)

106.40 (104.35,107.68)

108.00 (106.20,109.30)

0.135

BUN, mmol/L

4.26 (3.96,5.64)

4.07 (3.46,5.07)

5.19 (4.05,6.09)

0.132

Cr, μmol/L

66.00 (56.50,80.00)

60.50 (55.50,80.75)

67.00 (58.50,83.00)

0.484

Myocardial injury markers

CK

107.00 (75.50,143.50)

99.00 (76.50,171.25)

107.00 (74.00,134.50)

0.786

CK-MB

1.83 (1.20,2.01)

1.72 (1.16,2.23)

1.83 (1.20,1.97)

0.384

LDH

175.00 (171.00,194.75)

172.00 (166.00,218.00)

176.00 (171.00,191.00)

0.238

Blood coagulation

PT

10.50 (10.25,10.75)

10.50 (10.33,10.78)

10.50 (10.15,10.75)

0.316

APTT

32.90 (29.55,34.75)

33.45 (29.08,34.98)

32.60 (29.55,35.00)

0.926

D-Dimer

0.06 (0.04,0.12)

0.06 (0.04,0.26)

0.06 (0.04,0.12)

0.217

Inflammatory markers

CRP

0.85 (0.61,1.72)

0.86 (0.58,2.80)

0.81 (0.63,1.39)

0.152

PCT

0.05 (0.05,0.05)

0.05 (0.05,0.05)

0.05 (0.05,0.05)

0.149

  1. hUC-MSCs human umbilical cord mesenchymal stromal cells, IQR interquartile range, WBC white blood cell, NEU neutrophil, LYM lymphocyte, Mon monocyte, PLT platelet, Hb hemoglobin, ALT alanine aminotransferase, AST aspartate aminotransferase, Cr creatinine, BUN urea nitrogen, PT prothrombin time, CK creatine kinase, CK-MB creatine kinase-MB, LDH lactate dehydrogenase, APTT activated partial thromboplastin time, CRP C-reactive protein, PCT procalcitonin
  2. # hUC-MSCs group compared with control group